The insider sales are small and routine relative to HCA's size. Monitor next 10-Q for any change in operating trends, particularly the $400M unfavorable payer mix shift noted in Q3 earnings.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 9 $504.89entry
- T+1 · 7d ago −0.09%α +0.27% · $504.42
- T+5 · 19h ago +1.36%α +3.06% · $511.78
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two HCA executives (EVP/COO Foster and EVP/Chief Clinical Officer Schlosser) sold a combined ~$1.43M in open-market shares this week, with Foster also exercising options and surrendering shares for tax withholding. The sales follow HCA's Q3 earnings (reported Oct 27) and a $1.95B debt issuance (Nov 5), but the open-market sales are small relative to HCA's market cap (estimated ~$130B), making them routine portfolio adjustments rather than a material signal.
Key Financial Metrics
Key Facts
- EVP/COO Foster sold ~$839K in open-market shares on Nov 6 (no 10b5-1 plan)
- EVP/Chief Clinical Officer Schlosser sold ~$594K in open-market shares on Nov 4 (no 10b5-1 plan)
- Foster also exercised 35,880 options at $145.24/share and surrendered 20,309 shares for tax withholding on Nov 4
- Total open-market sales by both executives: ~$1.43M, well under 0.1% of HCA's estimated $130B market cap
- HCA reported Q3 2026 revenue of $19.849B (+3.6% YoY) and GAAP EPS of $7.27 (+4.5% YoY) on Oct 27
- HCA issued $1.95B in senior notes on Nov 5
Financial Impact
Open-market sales of ~$1.43M represent less than 0.001% of HCA's estimated market cap
Risk Factors
- Insider sales are small and not indicative of material negative sentiment
- No unusual selling pattern detected beyond routine post-earnings window
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-HCA-1794348587547 |
Track record
19 reports on HCA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $506.04 Now $511.78 +1.13% settles Feb 9
- Nov 6, 202610d ago SC 13D/A Neutral 2/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Viewing Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $494.99 Now $511.78 +3.39% settles Feb 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 2, 202614d ago 8-K Neutral 3/10 Entry $462.86 Now $511.78 +10.57% settles Feb 1
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $473.19 Now $511.78 +8.16% settles Jan 28
- Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $463.22 Now $511.78 +10.48% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers